Haleema Surgical Hospital
Jhang, Punjab Province, 54000, Pakistan
NCT Number: NCT06996002
Upper Cross Syndrome (UCS) is characterized by weakening of the neck flexors and rhomboids and stiffness in the pectoralis major, upper trapezius, and levator scapulae. Rhomboids major and minor need to be strengthened in order to enhance scapular stability and regain proper posture. The aim of this study is to determine effect of rhomboids strength training regime on pain, craniovertebral angle and disability among patients with upper crossed syndrome.
Trial opening soon.
Get Notified20 year–45 year
All sexes
Interventional
Not applicable
Jhang, Punjab Province, 54000, Pakistan
This study will be a randomized controlled trial and will be conducted in Haleema Surgical Hospital, Shorkot city. Non-probability convenient sampling will be used to collect the data. Sample size of 38 subjects with age group between 20-45 years will be taken. Data will be collected from the patients having present complaint of upper crossed syndrome pain. Outcome measures will be taken using Numeric pain rating scale (NPRS) for pain, craniovertebral angle, and neck disability index questionnaire for disability. An informed consent will be taken. Subjects will be selected on the basis of inclusion and exclusion criteria and will be equally divided into two groups by computer-generated stratified randomization. The study will be a single-blind assessor. Both the Groups will receive Hot Pack, TENS, posture training and stretching exercises while group A will receive rhomboids strengthening exercises additionally. Outcome measures will be measured at baseline and after 4 weeks. Data analysis will be done by SPSS version 25.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Conventional treatment Modalities:
Trans-cutaneous Electric Nerve Stimulation (TENS) and Hot pack, postural exercises and stretching exercises
Conventional Treatment
releasing muscles of anterior part of the trunk, neck, shoulder.
Time frame: upto 4 weeks
Patient level of pain will be assessed using this scale. This scale ranges from 0 to 10.
0 indicates "no pain" 1-3 indicate "Mild pain" 4-6 indicate "Moderate pain" 7-10 indicate "worst pain". NPRS have shown high test-retest reliability (r = 0.96 and 0.95, respectively)
Time frame: upto 4 weeks
The NDI is a 10-item, 50-point index that evaluates many facets of day-to-day functioning in individuals with neck pain. The NDI evaluates two items pertaining to discretionary daily living activities (personal care, reading), four items pertaining to activities of daily living (lifting, work, driving, and recreation), and four items related subjective symptoms (pain intensity, headache, concentration, and sleeping). The scores are interpreted as follows:
0-4: No disability 5-14: Mild disability 15-24: Moderate disability 25-34: Severe disability 35-50: Complete disability. For the NDI, test-retest reliability was good
Time frame: upto 4 weeks
Anatomically speaking, the degree of forward head posture is measured using the craniovertebral angle (CVA), which is a measurement of the head and neck posture. It is the angle created by a horizontal line running from the C7 vertebra and the line joining the tragus of the ear to the vertebra (the seventh cervical vertebra).
In order to calculate the craniovertebral angle:
Contact information is provided by the study sponsor or research team.
Bisma Batool, MSPT
CONTACT
Samrood Akram, PhD Scholar
CONTACT
Riphah International University
Other
Effects of Rhomboids Strength Training Regime on Pain, Craniovertebral Angle and Disability Among Patients With Upper Crossed Syndrome
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07064031
Neurologic Manifestations, Oculocerebral hypopigmentation syndrome type Preus
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT06407700
Behavior, Motor Activity
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT06509594
Neurologic Manifestations, Oculocerebral hypopigmentation syndrome type Preus
Sargodha, Punjab Province, Pakistan
View Trial DetailsNCT07702604
Neck Pain, Neurologic Manifestations
Lahore, Punjab Province, Pakistan
View Trial Details